PDF(2540 KB)
iRoot BP Plus冠髓切断术治疗乳磨牙部分不可复性牙髓炎的回顾性研究
胡晓燕, 赵春晖, 王璐, 张正, 杨帆, 张红艳
PDF(2540 KB)
PDF(2540 KB)
iRoot BP Plus冠髓切断术治疗乳磨牙部分不可复性牙髓炎的回顾性研究
), 赵春晖1, 王璐2, 张正3, 杨帆2, 张红艳2A retrospective study on iRoot BP Plus full pulpotomy for primary molars with partial irreversible pulpitis
), Zhao Chunhui1, Wang Lu2, Zhang Zheng3, Yang Fan2, Zhang Hongyan2目的 回顾性观察iRoot BP Plus冠髓切断术治疗乳磨牙部分不可复性牙髓炎的临床疗效。 方法 收集2019年1月—2023年8月行乳磨牙iRoot BP Plus冠髓切断术治疗且随访24~47个月的部分不可复性牙髓炎病例102例，根据术前有无不可复性牙髓炎症状将纳入病例分为无症状组（n=53）和有症状组（n=49），观察两组的临床和影像学成功率。 结果 无症状组和有症状组的临床成功率分别为96.2%和97.9%，影像学成功率分别为96.2%和93.9%。 结论 在高抗菌等级前提下，iRoot BP Plus冠髓切断术可以尝试用于治疗乳磨牙部分不可复性冠髓炎。
Objective This study aimed to observe the outcomes of iRoot BP Plus full pulpotomy in primary molars with partial irreversible pulpitis retrospectively. Methods Collect 102 cases of primary molars with partial irreversible pulpitis undergoing iRoot BP Plus full pulpotomy from January 2019 to August 2023, with a follow-up period of 24-47 months. Based on the presence of irreversible pulpitis symptoms before surgery, the included cases will be divided into asymptomatic group (n=53) and symptomatic group (n=49). Observe the clinical and imaging success rates of both groups. Results Clinical success rates were 96.2% and 97.9% in asymptomatic and symptomatic groups, and radiographic success rates were 96.2% and 93.9% respectively. Conclusion iRoot BP Plus full pulpotomy can be used for the treatment of primary molars with partial irreversible pulpitis under an enhanced pulpotomy protocol.
不可复性牙髓炎 / 部分不可复性牙髓炎 / iRoot BP Plus / 冠髓切断术 / 乳磨牙
irreversible pulpitis / partial irreversible pulpitis / iRoot BP Plus / pulpotomy / primary molar
R788
| 1 | 周学东. 牙体牙髓病学[M]. 5版.北京: 人民卫生出版社, 2020: 167. |
| 1 | Zhou XD. Operative?dentistry?and?endodontics[M].?5th?ed. Beijing:?People’s?Medical?Publishing?House,?2020: 167. |
| 2 | AAE position statement on vital pulp therapy[J]. J Endod, 2021, 47(9): 1340-1344. |
| 3 | Guideline on pulp therapy for primary and immature permanent teeth[J]. Pediatr Dent, 2016, 38(6): 280-288. |
| 4 | Duncan HF, Galler KM, Tomson PL, et al. European Society of Endodontology position statement: management of deep caries and the exposed pulp[J]. Int Endod J, 2019, 52(7): 923-934. |
| 5 | Ricucci D, Loghin S, Siqueira JF Jr. Correlation bet-ween clinical and histologic pulp diagnoses[J]. J Endod, 2014, 40(12): 1932-1939. |
| 6 | Asgary S, Eghbal MJ, Ghoddusi J. Two-year results of vital pulp therapy in permanent molars with irreversible pulpitis: an ongoing multicenter randomized clinical trial[J]. Clin Oral Invest, 2014, 18(2): 635-641. |
| 7 | Asgary S, Eghbal MJ, Fazlyab M, et al. Five-year results of vital pulp therapy in permanent molars with irrever-sible pulpitis: a non-inferiority multicenter randomized clinical trial[J]. Clin Oral Invest, 2015, 19(2): 335-341. |
| 8 | Taha NA, Khazali MA. Partial pulpotomy in mature permanent teeth with clinical signs indicative of irreversible pulpitis: a randomized clinical trial[J]. J Endod, 2017, 43(9): 1417-1421. |
| 9 | Taha NA, Abdulkhader SZ. Full pulpotomy with biodentine in symptomatic young permanent teeth with carious exposure[J]. J Endod, 2018, 44(6): 932-937. |
| 10 | Uesrichai N, Nirunsittirat A, Chuveera P, et al. Partial pulpotomy with two bioactive cements in permanent tee-th of 6- to 18-year-old patients with signs and symptoms indicative of irreversible pulpitis: a noninferiority randomized controlled trial[J]. Int Endod J, 2019, 52(6): 749-759. |
| 11 | 彭楚芳, 赵玉鸣, 杨媛, 等. 三氧化矿物凝聚体牙髓切断术治疗年轻恒牙不可复性牙髓炎的初步研究[J]. 中华口腔医学杂志, 2015, 50(12): 715-719. |
| 11 | Peng CF, Zhao YM, Yang Y, et al. Mineral trioxide aggragate pulpotomy for the treatment of immature permanent teeth with irreversible pulpitis: a preliminary clinical study[J]. Chin J Stomatol, 2015, 50(12): 715-719. |
| 12 | 肖文, 史文涛, 汪俊. 炎性活髓保存在年轻恒牙不可逆性牙髓炎及根尖周炎治疗中的应用[J]. 中华口腔医学杂志, 2022, 57(3): 287-291. |
| 12 | Xiao W, Shi WT, Wang J. Study of vital inflamed pulp therapy in immature permanent teeth with irreversible pulpitis and apical periodontitis[J]. Chin J Stomatol, 2022, 57(3): 287-291. |
| 13 | Linsuwanont P, Wimonsutthikul K, Pothimoke U, et al. Treatment outcomes of mineral trioxide aggregate pul-potomy in vital permanent teeth with carious pulp exposure: the retrospective study[J]. J Endod, 2017, 43(2): 225-230. |
| 14 | Asgary S, Eghbal MJ. Treatment outcomes of pulpotomy in permanent molars with irreversible pulpitis using biomaterials: a multi-center randomized controlled trial[J]. Acta Odontol Scand, 2013, 71(1): 130-136. |
| 15 | Taha NA, Abdelkhader SZ. Outcome of full pulpotomy using Biodentine in adult patients with symptoms indicative of irreversible pulpitis[J]. Int Endod J, 2018, 51(8): 819-828. |
| 16 | Asgary S, Eghbal MJ, Bagheban AA. Long-term outcomes of pulpotomy in permanent teeth with irreversible pulpitis: a multi-center randomized controlled trial[J]. Am J Dent, 2017, 30(3): 151-155. |
| 17 | Smith AJ, Duncan HF, Diogenes A, et al. Exploiting the bioactive properties of the dentin-pulp complex in regenerative endodontics[J]. J Endod, 2016, 42(1): 47-56. |
| 18 | Memarpour M, Fijan S, Asgary S, et al. Calcium-enriched mixture pulpotomy of primary molar teeth with irreversible pulpitis. A clinical study[J]. Open Dent J, 2016, 10: 43-49. |
| 19 | Asgary S, Sarraf Shirazi A, Sabbagh S. Management of primary molars with irreversible pulpitis employing tampon pulpotomy: report of three cases with 34-month mean follow-up[J]. Clin Case Rep, 2021, 9(4): 2289-2294. |
| 20 | Ricucci D, Siqueira JF Jr, Li Y, et al. Vital pulp therapy: histopathology and histobacteriology-based guidelines to treat teeth with deep caries and pulp exposure[J]. J Dent, 2019, 86: 41-52. |
| 21 | Aaminabadi NA, Parto M, Emamverdizadeh P, et al. Pulp bleeding color is an indicator of clinical and histohematologic status of primary teeth[J]. Clin Oral Investig, 2017, 21(5): 1831-1841. |
| 22 | Wolters WJ, Duncan HF, Tomson PL, et al. Minimally invasive endodontics: a new diagnostic system for assessing pulpitis and subsequent treatment needs[J]. Int Endod J, 2017, 50(9): 825-829. |
| 23 | Rajasekharan S, Martens LC, Vandenbulcke J, et al. Efficacy of three different pulpotomy agents in primary molars: a randomized control trial[J]. Int Endod J, 2017, 50(3): 215-228. |
| 24 | ?elik BN, Mutluay MS, Ar?kan V, et al. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth[J]. Clin Oral Investig. 2019, 23(2): 661-666. |
| 25 | Rao Q, Kuang J, Mao C, et al. Comparison of iRoot BP Plus and calcium hydroxide as pulpotomy materials in permanent incisors with complicated crown fractures: a retrospective study[J]. J Endod, 2020, 46(3): 352-357. |
| 26 | Yang Y, Xia B, Xu Z, et al. The effect of partial pulpotomy with iRoot BP Plus in traumatized immature permanent teeth: a randomized prospective controlled trial[J]. Dent Traumatol, 2020, 36(5): 518-525. |
| 27 | Hu X, Li Y, Xu J, et al. Immature permanent incisors with complicated crown fractures treated with partial pulpotomy using white mineral trioxide aggregate and IRoot BP plus-a retrospective long-term study[J]. Dent Traumatol, 2023, 39(2): 165-172. |
| 28 | Hafez AA, Cox CF, Tarim B, et al. An in vivo evaluation of hemorrhage control using sodium hypochlorite and direct capping with a one- or two-component adhesive system in exposed nonhuman primate pulps[J]. Quintessence Int, 2002, 33(4): 261-272. |
/
| 〈 |
|
〉 |
AI Summary
